HCA Healthcare, Inc. (HCA) EBITDA Margin: 20.64%
Is HCA Healthcare, Inc.’s EBITDA margin high or low?
HCA Healthcare, Inc.'s EBITDA margin of 20.64% is in line with its 5-year average of 20.85%, around the middle of its 5-year range (18.89%–24.26%).
As of Tuesday, June 16, 2026. 2.38% above its 12-month average of 20.16%.
HCA EBITDA Margin Chart
HCA Average EBITDA Margin Chart
HCA Current vs Average EBITDA Margin Chart
HCA EBITDA Margin Metrics
EBITDA MARGIN
20.64%
EBITDA MARGIN AVG TTM
20.16%
EBITDA MARGIN AVG 3Y
20.49%
EBITDA MARGIN AVG 5Y
20.85%
EBITDA MARGIN AVG 10Y
20.20%
EBITDA MARGIN AVG 15Y
19.73%
EBITDA MARGIN AVG 20Y
19.39%
CURRENT VS TTM AVG
+2.38%
CURRENT VS 3Y AVG
+0.73%
CURRENT VS 5Y AVG
-1.02%
CURRENT VS 10Y AVG
+2.16%
CURRENT VS 15Y AVG
+4.61%
CURRENT VS 20Y AVG
+6.43%
HCA Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCA Healthcare, Inc. (HCA) | $88.05B | 20.64% | 20.16% | 20.49% | 20.85% |
| Elevance Health Inc. (ELV)vs › | $86.74B | 4.85% | 5.39% | 5.84% | 6.22% |
| Cigna Corporation (CI)vs › | $77.02B | 4.22% | 4.42% | 5.04% | 5.39% |
| Medtronic plc (MDT)vs › | $104.05B | 26.97% | 27.23% | 26.91% | 26.72% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $62.78B | 40.57% | 39.01% | 39.25% | 44.24% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $113.82B | 40.28% | 22.34% | 35.25% | 38.74% |
| Bristol-Myers Squibb Company (BMY)vs › | $114.38B | 30.18% | 18.37% | 30.35% | 29.39% |
| Cencora, Inc. (COR)vs › | $54.76B | 1.16% | 1.15% | 1.23% | 0.63% |
| Cardinal Health, Inc. (CAH)vs › | $53.55B | 1.40% | 1.13% | 0.75% | 0.34% |
| Becton, Dickinson and Company (BDX)vs › | $52.72B | 22.70% | 23.29% | 23.17% | 22.44% |
Margin Comparison
Gross Margin
34.9%
EBITDA Margin
20.6%
Operating Margin
15.7%
Net Margin
8.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
HCA Healthcare, Inc. EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
HCA Healthcare, Inc. EBITDA Margin FAQ
- What is the EBITDA margin for HCA Healthcare, Inc. (HCA)?
- The EBITDA margin for HCA stock is 20.64%.
- Is HCA Healthcare, Inc.'s EBITDA margin high or low?
- HCA Healthcare, Inc.'s EBITDA margin of 20.64% is in line with its 5-year average of 20.85%, around the middle of its 5-year range (18.89%–24.26%).
- What is the TTM average EBITDA margin for HCA Healthcare, Inc. (HCA)?
- The TTM average EBITDA margin for HCA stock is 20.16%.
- What is the 3Y average EBITDA margin for HCA Healthcare, Inc. (HCA)?
- The 3Y average EBITDA margin for HCA stock is 20.49%.
- What is the 5Y average EBITDA margin for HCA Healthcare, Inc. (HCA)?
- The 5Y average EBITDA margin for HCA stock is 20.85%.
- What is the 10Y average EBITDA margin for HCA Healthcare, Inc. (HCA)?
- The 10Y average EBITDA margin for HCA stock is 20.20%.
- What is the 15Y average EBITDA margin for HCA Healthcare, Inc. (HCA)?
- The 15Y average EBITDA margin for HCA stock is 19.73%.
- What is the 20Y average EBITDA margin for HCA Healthcare, Inc. (HCA)?
- The 20Y average EBITDA margin for HCA stock is 19.39%.
HCA Healthcare, Inc. EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | 20.64% |
| 2024-12-31 | 19.68% |
| 2023-12-31 | 19.58% |
| 2022-12-31 | 22.06% |
| 2021-12-31 | 24.26% |
| 2020-12-31 | 18.89% |
| 2019-12-31 | 18.82% |
| 2018-12-31 | 20.07% |
| 2017-12-31 | 18.81% |
| 2016-12-31 | 20.45% |
| 2015-12-31 | 18.97% |
| 2014-12-31 | 19.08% |
| 2013-12-31 | 19.15% |
| 2012-12-31 | 19.30% |
| 2011-12-31 | 21.73% |
| 2010-12-31 | 18.74% |
| 2009-12-31 | 18.02% |
| 2008-12-31 | 16.24% |
| 2007-12-31 | 17.99% |
| 2006-12-31 | 15.73% |
| 2005-12-31 | 17.08% |
| 2004-12-31 | 16.11% |
| 2003-12-31 | 18.52% |
| 2002-12-31 | 15.60% |
| 2001-12-31 | 18.33% |
| 2000-12-31 | 105.49% |
| 1999-12-31 | 105.25% |
| 1998-12-31 | 100.00% |
| 1997-12-31 | 15.15% |
| 1996-12-31 | 20.30% |
Related Metrics
About HCA Healthcare, Inc.
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Samuel N. Hazen